pyrazines has been researched along with Low Bone Density in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegazy, SK | 1 |
| Issaragrisil, S; Kheolamai, P; Klincumhom, N; Manochantr, S; Sanvoranart, T; Supokawej, A; U-Pratya, Y; Wattanapanitch, M | 1 |
| Shibayama, H | 1 |
| Abe, M | 1 |
| Chaudhary, R; Ghose, A; Taj, A; Tariq, Z | 1 |
2 review(s) available for pyrazines and Low Bone Density
| Article | Year |
|---|---|
[Supportive care in multiple myeloma for continuing anti-myeloma therapies].
Topics: Anemia; Bone Density Conservation Agents; Bone Diseases, Metabolic; Boronic Acids; Bortezomib; Diphosphonates; Humans; Hypercalcemia; Kidney Diseases; Lenalidomide; Multiple Myeloma; Peripheral Nervous System Diseases; Pyrazines; Thalidomide | 2014 |
[Multiple myeloma].
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Boronic Acids; Bortezomib; Diphosphonates; Fractures, Bone; Humans; Hypercalcemia; Jaw Diseases; Multiple Myeloma; Osteonecrosis; Protease Inhibitors; Pyrazines | 2009 |
1 trial(s) available for pyrazines and Low Bone Density
| Article | Year |
|---|---|
Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women.
Topics: Absorptiometry, Photon; Aged; Alkaline Phosphatase; Amino Acids; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Lumbar Vertebrae; Metformin; Middle Aged; Osteocalcin; Osteogenesis; Osteoporosis, Postmenopausal; Postmenopause; Pyrazines; Sitagliptin Phosphate; Triazoles | 2015 |
2 other study(ies) available for pyrazines and Low Bone Density
| Article | Year |
|---|---|
Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Topics: Adipogenesis; Alkaline Phosphatase; Bone Diseases, Metabolic; Boronic Acids; Bortezomib; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Female; Humans; Integrin-Binding Sialoprotein; Mesenchymal Stem Cells; Osteoblasts; Osteogenesis; Osteoporosis; Placenta; Pregnancy; Pyrazines; Sp7 Transcription Factor; Transcription Factors; Up-Regulation | 2014 |
Acute dyspnea from treatment of AL amyloidisis with bortezomib.
Topics: Acute Disease; Aged; Amyloidosis; Bone Diseases, Metabolic; Boronic Acids; Bortezomib; Dyspnea; Humans; Kidney Diseases; Male; Middle Aged; Protease Inhibitors; Pyrazines | 2011 |